{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:48:59Z","timestamp":1769089739732,"version":"3.49.0"},"publisher-location":"Singapore","reference-count":269,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811391507","type":"print"},{"value":"9789811391514","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-13-9151-4_4","type":"book-chapter","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T02:01:46Z","timestamp":1574042506000},"page":"71-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunopathogenesis of HBV Infection"],"prefix":"10.1007","author":[{"given":"Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJM199106133242405","volume":"324","author":"TJ Liang","year":"1991","unstructured":"Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E (1991) A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324:1705\u20131709","journal-title":"N Engl J Med"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0168-8278(90)90062-V","volume":"10","author":"MR Brunetto","year":"1990","unstructured":"Brunetto MR et al (1990) A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 10:258\u2013261","journal-title":"J Hepatol"},{"key":"4_CR3","first-page":"888","volume":"23","author":"JL Hou","year":"2015","unstructured":"Hou JL, Lai W (2015) The guideline of prevention and treatment for chronic hepatitis B: a 2015 update. Zhonghua Gan Zang Bing Za Zhi 23:888\u2013905","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0016-5085(99)70187-3","volume":"116","author":"HM Diepolder","year":"1999","unstructured":"Diepolder HM et al (1999) Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology 116:650\u2013657","journal-title":"Gastroenterology"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0016-5085(99)70203-9","volume":"116","author":"DR Milich","year":"1999","unstructured":"Milich DR (1999) Do T cells \u201csee\u201d the hepatitis B core and e antigens differently? Gastroenterology 116:765\u2013768","journal-title":"Gastroenterology"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1128\/JCM.39.9.3200-3203.2001","volume":"39","author":"E Alestig","year":"2001","unstructured":"Alestig E, Hannoun C, Horal P, Lindh M (2001) Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant. J Clin Microbiol 39:3200\u20133203","journal-title":"J Clin Microbiol"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1590\/0074-02760160540","volume":"112","author":"S Chacha","year":"2017","unstructured":"Chacha S et al (2017) Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases. Mem Inst Oswaldo Cruz 112:626\u2013631","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virusres.2017.03.021","volume":"235","author":"H Zhou","year":"2017","unstructured":"Zhou H et al (2017) Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer. Virus Res 235:86\u201395","journal-title":"Virus Res"},{"key":"4_CR9","unstructured":"Norder H et al (2019) High frequency of either altered pre-core startcodon or weakened kozak sequence in the corepromoter region in hepatitis B virus A1 strains from Rwanda. Genes (Basel) 10"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.virol.2017.02.020","volume":"505","author":"L Zong","year":"2017","unstructured":"Zong L et al (2017) Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region. Virology 505:155\u2013161","journal-title":"Virology"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.20553","volume":"41","author":"TF Baumert","year":"2005","unstructured":"Baumert TF et al (2005) Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Hepatology 41:247\u2013256","journal-title":"Hepatology"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/hep.510280530","volume":"28","author":"M Sterneck","year":"1998","unstructured":"Sterneck M et al (1998) Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 28:1390\u20131397","journal-title":"Hepatology"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","volume":"336","author":"WF Carman","year":"1990","unstructured":"Carman WF et al (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325\u2013329","journal-title":"Lancet"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1053\/jhep.2003.50484","volume":"38","author":"T Kalinina","year":"2003","unstructured":"Kalinina T, Iwanski A, Will H, Sterneck M (2003) Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274\u20131281","journal-title":"Hepatology"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1034\/j.1600-6143.2003.00149.x","volume":"3","author":"JJ Germer","year":"2003","unstructured":"Germer JJ, Charlton MR, Ishitani MB, Forehand CD, Patel R (2003) Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant. Am J Transplant 3:743\u2013753","journal-title":"Am J Transplant"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1086\/373902","volume":"187","author":"MLAT Lorentza","year":"2003","unstructured":"Lorentza MLAT (2003) De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti\u2013hepatitis B surface antibody. J Infect Dis 187:1323\u20131326","journal-title":"J Infect Dis"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","volume":"83","author":"S Asabe","year":"2009","unstructured":"Asabe S et al (2009) The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 83:9652\u20139662","journal-title":"J Virol"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"e1002159","DOI":"10.1371\/journal.ppat.1002159","volume":"7","author":"Y Tian","year":"2011","unstructured":"Tian Y, Chen WL, Ou JH (2011) Effects of interferon-alpha\/beta on HBV replication determined by viral load. PLoS Pathog 7:e1002159","journal-title":"PLoS Pathog"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.1128\/JVI.01087-12","volume":"86","author":"Y Tian","year":"2012","unstructured":"Tian Y, Chen WL, Kuo CF, Ou JH (2012) Viral-load-dependent effects of liver injury and regeneration on hepatitis B virus replication in mice. J Virol 86:9599\u20139605","journal-title":"J Virol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3748\/wjg.v24.i30.3347","volume":"24","author":"IM Akcay","year":"2018","unstructured":"Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L (2018) Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J Gastroenterol 24:3347\u20133360","journal-title":"World J Gastroenterol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1093\/hmg\/ddr301","volume":"20","author":"H Mbarek","year":"2011","unstructured":"Mbarek H et al (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 20:3884\u20133892","journal-title":"Hum Mol Genet"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y et al (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41:591\u2013595","journal-title":"Nat Genet"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"11664","DOI":"10.1038\/ncomms11664","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y et al (2016) Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese. Nat Commun 7:11664","journal-title":"Nat Commun"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"e86007","DOI":"10.1371\/journal.pone.0086007","volume":"9","author":"N Posuwan","year":"2014","unstructured":"Posuwan N et al (2014) Genetic association of human leukocyte antigens with chronicity or resolution of hepatitis B infection in thai population. PLoS One 9:e86007","journal-title":"PLoS One"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/ng.2809","volume":"45","author":"Z Hu","year":"2013","unstructured":"Hu Z et al (2013) New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet 45:1499\u20131503","journal-title":"Nat Genet"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajhg.2014.12.024","volume":"96","author":"MJ Lewis","year":"2015","unstructured":"Lewis MJ et al (2015) UBE2L3 polymorphism amplifies NF-kappaB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet 96:221\u2013234","journal-title":"Am J Hum Genet"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"e10693","DOI":"10.1371\/journal.pone.0010693","volume":"5","author":"T Zeller","year":"2010","unstructured":"Zeller T et al (2010) Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One 5:e10693","journal-title":"PLoS One"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/hmg\/ddt266","volume":"22","author":"YJ Kim","year":"2013","unstructured":"Kim YJ et al (2013) A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet 22:4233\u20134238","journal-title":"Hum Mol Genet"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"a016246","DOI":"10.1101\/cshperspect.a016246","volume":"7","author":"S Pandey","year":"2014","unstructured":"Pandey S, Kawai T, Akira S (2014) Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol 7:a016246","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.4049\/jimmunol.175.5.3165","volume":"175","author":"A Cooper","year":"2005","unstructured":"Cooper A, Tal G, Lider O, Shaul Y (2005) Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol 175:3165\u20133176","journal-title":"J Immunol"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jhep.2015.06.022","volume":"63","author":"S Luangsay","year":"2015","unstructured":"Luangsay S et al (2015) Expression and functionality of Toll- and RIG-like receptors in HepaRG cells. J Hepatol 63:1077\u20131085","journal-title":"J Hepatol"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jhep.2015.07.014","volume":"63","author":"S Luangsay","year":"2015","unstructured":"Luangsay S et al (2015) Early inhibition of hepatocyte innate responses by hepatitis B virus. J Hepatol 63:1314\u20131322","journal-title":"J Hepatol"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1128\/JVI.02903-15","volume":"90","author":"N Montfoort van","year":"2016","unstructured":"van Montfoort N et al (2016) Hepatitis B virus surface antigen activates myeloid dendritic cells via a soluble CD14-dependent mechanism. J Virol 90:6187\u20136199","journal-title":"J Virol"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1046\/j.1432-1327.2001.02385.x","volume":"268","author":"T Muta","year":"2001","unstructured":"Muta T, Takeshige K (2001) Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur J Biochem 268:4580\u20134589","journal-title":"Eur J Biochem"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"e1006296","DOI":"10.1371\/journal.ppat.1006296","volume":"13","author":"Y Liu","year":"2017","unstructured":"Liu Y et al (2017) Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog 13:e1006296","journal-title":"PLoS Pathog"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","volume":"42","author":"S Sato","year":"2015","unstructured":"Sato S et al (2015) The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42:123\u2013132","journal-title":"Immunity"},{"key":"4_CR37","first-page":"S4","volume":"5","author":"GV Shravanthi","year":"2015","unstructured":"Shravanthi GV, Mukherjee RM, Reddy PB, Rao PN, Rao DN (2015) HBV induce cytosolic DNA sensor cGAS but suppress IRF3 to prevent generation of antiviral defense mechanism in infected cell. Mol Cell Biol 5:S4","journal-title":"Mol Cell Biol"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","volume":"137","author":"C Dunn","year":"2009","unstructured":"Dunn C et al (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137:1289\u20131300","journal-title":"Gastroenterology"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41467-018-02969-8","volume":"9","author":"AM Ortega-Prieto","year":"2018","unstructured":"Ortega-Prieto AM et al (2018) 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat Commun 9:682","journal-title":"Nat Commun"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1128\/JVI.02507-06","volume":"81","author":"P Vanlandschoot","year":"2007","unstructured":"Vanlandschoot P, Van Houtte F, Serruys B, Leroux-Roels G (2007) Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator. J Virol 81:2535\u20132536","journal-title":"J Virol"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/v9050095","volume":"9","author":"S Faure-Dupuy","year":"2017","unstructured":"Faure-Dupuy S, Lucifora J, Durantel D (2017) Interplay between the hepatitis B virus and innate immunity: from an understanding to the development of therapeutic concepts. Viruses 9:95","journal-title":"Viruses"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Chisari FV (2005) Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79:9369\u20139380","journal-title":"J Virol"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1073\/pnas.0401771101","volume":"101","author":"S Wieland","year":"2004","unstructured":"Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101:6669\u20136674","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4_CR44","doi-asserted-by":"publisher","first-page":"2074-2083.e2","DOI":"10.1053\/j.gastro.2011.02.057","volume":"140","author":"Marc L\u00fctgehetmann","year":"2011","unstructured":"Lutgehetmann M et al (2011) Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice. Gastroenterology 140. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.057","journal-title":"Gastroenterology"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00430-014-0370-1","volume":"204","author":"E Zhang","year":"2015","unstructured":"Zhang E, Lu M (2015) Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol 204:11\u201320","journal-title":"Med Microbiol Immunol"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","volume":"190","author":"S Wang","year":"2013","unstructured":"Wang S et al (2013) Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes\/macrophages by interfering with JNK activation. J Immunol 190:5142\u20135151","journal-title":"J Immunol"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/hep.21482","volume":"45","author":"K Visvanathan","year":"2007","unstructured":"Visvanathan K et al (2007) Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102\u2013110","journal-title":"Hepatology"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.22751","volume":"49","author":"J Wu","year":"2009","unstructured":"Wu J et\u00a0al (2009) Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49:1132\u20131140","journal-title":"Hepatology"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hep.26064","volume":"57","author":"J Chen","year":"2013","unstructured":"Chen J et\u00a0al (2013) Hepatitis B virus polymerase impairs interferon-alpha-induced STA T activation through inhibition of importin-alpha5 and protein kinase C-delta. Hepatology 57:470\u2013482","journal-title":"Hepatology"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.0903874","volume":"185","author":"C Wei","year":"2010","unstructured":"Wei C et al (2010) The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 185:1158\u20131168","journal-title":"J Immunol"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s13238-010-0141-8","volume":"1","author":"J Jiang","year":"2010","unstructured":"Jiang J, Tang H (2010) Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 1:1106\u20131117","journal-title":"Protein Cell"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.24505","volume":"54","author":"Q Han","year":"2011","unstructured":"Han Q, Zhang C, Zhang J, Tian Z (2011) Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54:1179\u20131189","journal-title":"Hepatology"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"e1000986","DOI":"10.1371\/journal.ppat.1000986","volume":"6","author":"H Wang","year":"2010","unstructured":"Wang H, Ryu WS (2010) Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6:e1000986","journal-title":"PLoS Pathog"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"S Yu","year":"2010","unstructured":"Yu S et al (2010) Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1\/IKKepsilon and DDX3. J Gen Virol 91:2080\u20132090","journal-title":"J Gen Virol"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.192.7.921","volume":"192","author":"K Kakimi","year":"2000","unstructured":"Kakimi K, Guidotti LG, Koezuka Y, Chisari FV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192:921\u2013930","journal-title":"J Exp Med"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/hep.26115","volume":"57","author":"Z Tian","year":"2013","unstructured":"Tian Z, Chen Y, Gao B (2013) Natural killer cells in liver disease. Hepatology 57:1654\u20131662","journal-title":"Hepatology"},{"key":"4_CR57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer U, Maini MK, Knolle PA (2012) Living in the liver: hepatic infections. Nat Rev Immunol 12:201\u2013213","journal-title":"Nat Rev Immunol"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","volume":"32","author":"GJ Webster","year":"2000","unstructured":"Webster GJ et al (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117\u20131124","journal-title":"Hepatology"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","volume":"107","author":"PL Yang","year":"2010","unstructured":"Yang PL et al (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci 107:798\u2013802","journal-title":"Proc Natl Acad Sci"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","volume":"284","author":"LG Guidotti","year":"1999","unstructured":"Guidotti LG et al (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825\u2013829","journal-title":"Science"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/gut.2008.163600","volume":"58","author":"P Fisicaro","year":"2009","unstructured":"Fisicaro P et al (2009) Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58:974\u2013982","journal-title":"Gut"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","volume":"67","author":"H Li","year":"2018","unstructured":"Li H et al (2018) Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection. Gut 67:2035\u20132044","journal-title":"Gut"},{"issue":"3","key":"4_CR63","doi-asserted-by":"publisher","first-page":"1151-1160.e7","DOI":"10.1053\/j.gastro.2009.05.047","volume":"137","author":"Barbara Oliviero","year":"2009","unstructured":"Oliviero B et al (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.047","journal-title":"Gastroenterology"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","volume":"54","author":"ET Tjwa","year":"2011","unstructured":"Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM (2011) Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 54:209\u2013218","journal-title":"J Hepatol"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"e1002594","DOI":"10.1371\/journal.ppat.1002594","volume":"8","author":"C Sun","year":"2012","unstructured":"Sun C et al (2012) TGF-beta1 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 8:e1002594","journal-title":"PLoS Pathog"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","volume":"52","author":"Y Ju","year":"2010","unstructured":"Ju Y et al (2010) T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 52:322\u2013329","journal-title":"J Hepatol"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1128\/JVI.07000-11","volume":"86","author":"ET Tjwa","year":"2012","unstructured":"Tjwa ET et al (2012) Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection. J Virol 86:4102\u20134109","journal-title":"J Virol"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","volume":"143","author":"J Martinet","year":"2012","unstructured":"Martinet J et\u00a0al (2012) Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. Gastroenterology 143:1586\u20131596.e8","journal-title":"Gastroenterology"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cei.12597","volume":"180","author":"Q Zheng","year":"2015","unstructured":"Zheng Q et al (2015) Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection. Clin Exp Immunol 180:499\u2013508","journal-title":"Clin Exp Immunol"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","volume":"210","author":"D Peppa","year":"2013","unstructured":"Peppa D et al (2013) Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 210:99\u2013114","journal-title":"J Exp Med"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jhep.2018.10.006","volume":"70","author":"A Schuch","year":"2019","unstructured":"Schuch A et al (2019) NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection. J Hepatol 70:351\u2013360","journal-title":"J Hepatol"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","volume":"27","author":"IN Crispe","year":"2009","unstructured":"Crispe IN (2009) The liver as a lymphoid organ. Annu Rev Immunol 27:147\u2013163","journal-title":"Annu Rev Immunol"},{"key":"4_CR73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jmor.1051430403","volume":"143","author":"JD Horton","year":"1974","unstructured":"Horton JD, Manning MJ (1974) Lymphoid organ development in Xenopus thymectomized at eight days of age. J Morphol 143:385\u2013396","journal-title":"J Morphol"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1038\/cti.2016.62","volume":"5","author":"KJ Brempelis","year":"2016","unstructured":"Brempelis KJ, Crispe IN (2016) Infiltrating monocytes in liver injury and repair. Clin Transl Immunol 5:e113","journal-title":"Clin Transl Immunol"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","volume":"61","author":"A Boltjes","year":"2014","unstructured":"Boltjes A, Movita D, Boonstra A, Woltman AM (2014) The role of Kupffer cells in hepatitis B and hepatitis C virus infections. J Hepatol 61:660\u2013671","journal-title":"J Hepatol"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.4049\/jimmunol.177.8.5517","volume":"177","author":"K Ono","year":"2006","unstructured":"Ono K et al (2006) Mannose-binding lectin augments the uptake of lipid A, Staphylococcus aureus, and Escherichia coli by Kupffer cells through increased cell surface expression of scavenger receptor A. J Immunol 177:5517\u20135523","journal-title":"J Immunol"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1099\/0022-1317-83-9-2279","volume":"83","author":"P Vanlandschoot","year":"2002","unstructured":"Vanlandschoot P et al (2002) LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J Gen Virol 83:2279\u20132289","journal-title":"J Gen Virol"},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.23226","volume":"50","author":"M Hosel","year":"2009","unstructured":"Hosel M et al (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50:1773\u20131782","journal-title":"Hepatology"},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1053\/gast.2001.29594","volume":"121","author":"R Uwatoku","year":"2001","unstructured":"Uwatoku R et al (2001) Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. Gastroenterology 121:1460\u20131472","journal-title":"Gastroenterology"},{"issue":"6","key":"4_CR80","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/hep.30510","volume":"69","author":"LL Wu","year":"2019","unstructured":"Wu LL et al (2019) Lymphocyte antigen 6 complex, locus C+monocytes and Kupffer cells orchestrate liver immune responses against hepatitis B virus in mice. Hepatology 69(6):2364\u20132380","journal-title":"Hepatology"},{"key":"4_CR81","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","volume":"12","author":"G Kolios","year":"2006","unstructured":"Kolios G, Valatas V, Kouroumalis E (2006) Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 12:7413\u20137420","journal-title":"World J Gastroenterol"},{"key":"4_CR82","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2893.2003.00412.x","volume":"10","author":"TJ Tang","year":"2003","unstructured":"Tang TJ et al (2003) The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J Viral Hepat 10:159\u2013167","journal-title":"J Viral Hepat"},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.21897","volume":"46","author":"J Wu","year":"2007","unstructured":"Wu J et\u00a0al (2007) Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46:1769\u20131778","journal-title":"Hepatology"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"e30360","DOI":"10.1371\/journal.pone.0030360","volume":"7","author":"MH Hong","year":"2012","unstructured":"Hong MH et al (2012) Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. PLoS One 7:e30360","journal-title":"PLoS One"},{"key":"4_CR85","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/hep.26668","volume":"59","author":"L Xu","year":"2014","unstructured":"Xu L, Yin W, Sun R, Wei H, Tian Z (2014) Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice. Hepatology 59:443\u2013452","journal-title":"Hepatology"},{"key":"4_CR86","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","volume":"195","author":"M Li","year":"2015","unstructured":"Li M et al (2015) Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B Core antigen-TLR2 interactions in mice. J Immunol 195:3100\u20133109","journal-title":"J Immunol"},{"key":"4_CR87","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3856","volume":"21","author":"LJ Pallett","year":"2015","unstructured":"Pallett LJ et al (2015) Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med 21:591\u2013600","journal-title":"Nat Med"},{"key":"4_CR88","doi-asserted-by":"crossref","unstructured":"Gill US, Pallett LJ, Kennedy PTF, Maini MK (2018) Liver sampling: a vital window into HBV pathogenesis on the path to functional cure. Gut. 67(4):767\u2013775","DOI":"10.1136\/gutjnl-2017-314873"},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.coph.2016.07.013","volume":"30","author":"ML Kyong-Mi Chang","year":"2016","unstructured":"Kyong-Mi Chang ML (2016) Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics. Curr Opin Pharmacol 30:93\u2013105","journal-title":"Curr Opin Pharmacol"},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","volume":"193","author":"A Huang","year":"2014","unstructured":"Huang A et al (2014) Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J Immunol 193:5461\u20135469","journal-title":"J Immunol"},{"issue":"10","key":"4_CR91","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/apt.15226","volume":"49","author":"S Pal","year":"2019","unstructured":"Pal S et al (2019) Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy. Aliment Pharmacol Ther 49(10):1346\u20131359","journal-title":"Aliment Pharmacol Ther"},{"key":"4_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2018.11.006","volume":"161","author":"Q Han","year":"2019","unstructured":"Han Q, Hou Z, Yin C, Zhang C, Zhang J (2019) 5\u2032-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice. Antivir Res 161:36\u201345","journal-title":"Antivir Res"},{"key":"4_CR93","doi-asserted-by":"publisher","first-page":"e1007690","DOI":"10.1371\/journal.ppat.1007690","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang F et al (2019) Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog 15:e1007690","journal-title":"PLoS Pathog"},{"key":"4_CR94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","volume":"16","author":"JL Baron","year":"2002","unstructured":"Baron JL et al (2002) Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583\u2013594","journal-title":"Immunity"},{"key":"4_CR95","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/intimm\/dxn046","volume":"20","author":"H Ito","year":"2008","unstructured":"Ito H et al (2008) Role of Valpha14+ NKT cells in the development of hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol 20:869\u2013879","journal-title":"Int Immunol"},{"key":"4_CR96","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2811","volume":"18","author":"S Zeissig","year":"2012","unstructured":"Zeissig S et al (2012) Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 18:1060\u20131068","journal-title":"Nat Med"},{"key":"4_CR97","doi-asserted-by":"publisher","first-page":"e28871","DOI":"10.1371\/journal.pone.0028871","volume":"6","author":"X Jiang","year":"2011","unstructured":"Jiang X et al (2011) Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS One 6:e28871","journal-title":"PLoS One"},{"key":"4_CR98","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00705-015-2539-3","volume":"160","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lei Y, Chen C, Ren H, Shi T (2015) Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection. Arch Virol 160:2535\u20132545","journal-title":"Arch Virol"},{"key":"4_CR99","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1111\/jcmm.13600","volume":"22","author":"Y Xu","year":"2018","unstructured":"Xu Y et al (2018) Tim-3 blockade promotes iNKT cell function to inhibit HBV replication. J Cell Mol Med 22:3192\u20133201","journal-title":"J Cell Mol Med"},{"key":"4_CR100","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1038\/ncomms11653","volume":"7","author":"B Wilgenburg van","year":"2016","unstructured":"van Wilgenburg B et al (2016) MAIT cells are activated during human viral infections. Nat Commun 7:11653","journal-title":"Nat Commun"},{"key":"4_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/1753425917714854","volume":"23","author":"YK Yong","year":"2017","unstructured":"Yong YK et al (2017) Decrease of CD69 levels on TCR Valpha7.2(+)CD4(+) innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. Innate Immun 23:459\u2013467","journal-title":"Innate Immun"},{"key":"4_CR102","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fimmu.2018.00472","volume":"9","author":"YK Yong","year":"2018","unstructured":"Yong YK et al (2018) Hyper-expression of PD-1 is associated with the levels of exhausted and dysfunctional phenotypes of circulating CD161++TCR iV\u03b17.2+ mucosal-associated invariant T cells in chronic hepatitis B virus infection. Front Immunol 9:472","journal-title":"Front Immunol"},{"key":"4_CR103","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/infdis\/jix425","volume":"216","author":"LL Boeijen","year":"2017","unstructured":"Boeijen LL et al (2017) Mucosal-associated invariant T cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy. J Infect Dis 216:969\u2013976","journal-title":"J Infect Dis"},{"key":"4_CR104","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","volume":"64","author":"A Bertoletti","year":"2016","unstructured":"Bertoletti A, Ferrari C (2016) Adaptive immunity in HBV infection. J Hepatol 64:S71\u2013S83","journal-title":"J Hepatol"},{"key":"4_CR105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/v1020091","volume":"1","author":"A Bertoletti","year":"2009","unstructured":"Bertoletti A, Tan A, Gehring A (2009) HBV-specific adaptive immunity. Viruses 1:91\u2013103","journal-title":"Viruses"},{"key":"4_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","volume":"13","author":"FV Chisari","year":"1995","unstructured":"Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29\u201360","journal-title":"Annu Rev Immunol"},{"key":"4_CR107","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti A, Gehring AJ (2006) The immune response during hepatitis B virus infection. J Gen Virol 87:1439\u20131449","journal-title":"J Gen Virol"},{"key":"4_CR108","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767\u2013811","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"4_CR109","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/JVI.75.4.1770-1782.2001","volume":"75","author":"YY Lew","year":"2001","unstructured":"Lew YY, Michalak TI (2001) In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J Virol 75(4):1770\u20131782","journal-title":"J Virol"},{"key":"4_CR110","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1099\/vir.0.80143-0","volume":"85","author":"S Tavakoli","year":"2004","unstructured":"Tavakoli S (2004) Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 85:2829\u20132836","journal-title":"J Gen Virol"},{"key":"4_CR111","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hep.21048","volume":"43","author":"A Untergasser","year":"2006","unstructured":"Untergasser A et al (2006) Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 43:539\u2013547","journal-title":"Hepatology"},{"key":"4_CR112","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3748\/wjg.v7.i4.537","volume":"7","author":"FS Wang","year":"2001","unstructured":"Wang FS et al (2001) Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7:537\u2013541","journal-title":"World J Gastroenterol"},{"key":"4_CR113","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/clim.2002.5245","volume":"104","author":"S Beckebaum","year":"2002","unstructured":"Beckebaum S et al (2002) Reduction in the circulating pDC1\/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 104:138\u2013150","journal-title":"Clin Immunol"},{"key":"4_CR114","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2249.2002.01943.x","volume":"130","author":"HF Lohr","year":"2002","unstructured":"Lohr HF et al (2002) Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B\u00a0\u2013 restoration by exogenous interleukin-12. Clin Exp Immunol 130:107\u2013114","journal-title":"Clin Exp Immunol"},{"key":"4_CR115","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/hep.20366","volume":"40","author":"RG Molen van der","year":"2004","unstructured":"van der Molen RG et al (2004) Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40:738\u2013746","journal-title":"Hepatology"},{"issue":"1","key":"4_CR116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.30637","volume":"70","author":"A Yonejima","year":"2019","unstructured":"Yonejima A et al (2019) Characteristics of impaired dendritic cell function in patients with hepatitis B virus infection. Hepatology 70(1):25\u201339","journal-title":"Hepatology"},{"key":"4_CR117","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/82161","volume":"6","author":"A Limmer","year":"2000","unstructured":"Limmer A et al (2000) Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6:1348\u20131354","journal-title":"Nat Med"},{"key":"4_CR118","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N et al (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 5:e1000313","journal-title":"PLoS Pathog"},{"key":"4_CR119","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe IN (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3:51\u201362","journal-title":"Nat Rev Immunol"},{"key":"4_CR120","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.4049\/jimmunol.1700921","volume":"200","author":"S Huang","year":"2018","unstructured":"Huang S et al (2018) Local stimulation of liver sinusoidal endothelial cells with a NOD1 agonist activates T cells and suppresses hepatitis B virus replication in mice. J Immunol 200:3170\u20133179","journal-title":"J Immunol"},{"key":"4_CR121","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.174.6.1565","volume":"174","author":"A Penna","year":"1991","unstructured":"Penna A et al (1991) Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174:1565\u20131570","journal-title":"J Exp Med"},{"key":"4_CR122","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.1073\/pnas.88.23.10445","volume":"88","author":"A Bertoletti","year":"1991","unstructured":"Bertoletti A et al (1991) HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 88:10445\u201310449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR123","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0168-8278(91)90074-L","volume":"13","author":"MC Jung","year":"1991","unstructured":"Jung MC et al (1991) Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 13:310\u2013317","journal-title":"J Hepatol"},{"key":"4_CR124","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.150.10.4659","volume":"150","author":"R Nayersina","year":"1993","unstructured":"Nayersina R et al (1993) HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150:4659\u20134671","journal-title":"J Immunol"},{"key":"4_CR125","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/JVI.01471-09","volume":"84","author":"WG Abbott","year":"2010","unstructured":"Abbott WG et al (2010) Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J Virol 84:621\u2013629","journal-title":"J Virol"},{"key":"4_CR126","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S0168-8278(01)00048-4","volume":"34","author":"Y Sobao","year":"2001","unstructured":"Sobao Y et al (2001) Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A\u22172402, the most common HLA class I allele in East Asia. J Hepatol 34:922\u2013929","journal-title":"J Hepatol"},{"key":"4_CR127","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.181.3.1047","volume":"181","author":"B Rehermann","year":"1995","unstructured":"Rehermann B et al (1995) The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 181:1047\u20131058","journal-title":"J Exp Med"},{"key":"4_CR128","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","volume":"143","author":"C Boni","year":"2012","unstructured":"Boni C et al (2012) Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology 143:963\u201373.e9","journal-title":"Gastroenterology"},{"key":"4_CR129","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R et al (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77:68\u201376","journal-title":"J Virol"},{"key":"4_CR130","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.0913498107","volume":"107","author":"PL Yang","year":"2010","unstructured":"Yang PL et al (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 107:798\u2013802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR131","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0952-7915(96)80034-3","volume":"8","author":"LG Guidotti","year":"1996","unstructured":"Guidotti LG, Chisari FV (1996) To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 8:478\u2013483","journal-title":"Curr Opin Immunol"},{"key":"4_CR132","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.159.4.2001","volume":"159","author":"A Franco","year":"1997","unstructured":"Franco A, Guidotti LG, Hobbs MV, Pasquetto V, Chisari FV (1997) Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol 159:2001\u20132008","journal-title":"J Immunol"},{"key":"4_CR133","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/JVI.66.2.1193-1198.1992","volume":"66","author":"A Penna","year":"1992","unstructured":"Penna A et al (1992) Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. J Virol 66:1193\u20131198","journal-title":"J Virol"},{"key":"4_CR134","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2018.02.019","volume":"153","author":"M Bourgine","year":"2018","unstructured":"Bourgine M et al (2018) Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine. Antivir Res 153:23\u201332","journal-title":"Antivir Res"},{"key":"4_CR135","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3892\/mmr.2017.7044","volume":"16","author":"S Bao","year":"2017","unstructured":"Bao S, Zheng J, Shi G (2017) The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Mol Med Rep 16:3713\u20133719","journal-title":"Mol Med Rep"},{"key":"4_CR136","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1084\/jem.20151218","volume":"213","author":"Z Zeng","year":"2016","unstructured":"Zeng Z et al (2016) Interferon-gamma facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance. J Exp Med 213:1079\u20131093","journal-title":"J Exp Med"},{"key":"4_CR137","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2006.08.003","volume":"25","author":"EM Shevach","year":"2006","unstructured":"Shevach EM (2006) From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195\u2013201","journal-title":"Immunity"},{"key":"4_CR138","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1440-1746.2007.05278.x","volume":"23","author":"IR Driel van","year":"2008","unstructured":"van Driel IR, Ang DK (2008) Role of regulatory T cells in gastrointestinal inflammatory disease. J Gastroenterol Hepatol 23:171\u2013177","journal-title":"J Gastroenterol Hepatol"},{"key":"4_CR139","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","volume":"79","author":"O Franzese","year":"2005","unstructured":"Franzese O et al (2005) Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 79:3322\u20133328","journal-title":"J Virol"},{"key":"4_CR140","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hep.20649","volume":"41","author":"JN Stoop","year":"2005","unstructured":"Stoop JN et al (2005) Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41:771\u2013778","journal-title":"Hepatology"},{"key":"4_CR141","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","volume":"177","author":"D Xu","year":"2006","unstructured":"Xu D et al (2006) Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 177:739\u2013747","journal-title":"J Immunol"},{"key":"4_CR142","doi-asserted-by":"publisher","first-page":"e0151717","DOI":"10.1371\/journal.pone.0151717","volume":"11","author":"KK Dietze","year":"2016","unstructured":"Dietze KK et al (2016) Characterization of the Treg response in the hepatitis B virus hydrodynamic injection mouse model. PLoS One 11:e0151717","journal-title":"PLoS One"},{"key":"4_CR143","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep.25765","volume":"56","author":"L Stross","year":"2012","unstructured":"Stross L et al (2012) Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 56:873\u2013883","journal-title":"Hepatology"},{"key":"4_CR144","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.imlet.2012.12.001","volume":"149","author":"B Yang","year":"2013","unstructured":"Yang B et al (2013) Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol Lett 149:41\u201349","journal-title":"Immunol Lett"},{"key":"4_CR145","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1172\/JCI44198","volume":"121","author":"J Publicover","year":"2011","unstructured":"Publicover J et\u00a0al (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121:1154\u20131162","journal-title":"J Clin Invest"},{"key":"4_CR146","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hep.26489","volume":"58","author":"Y Li","year":"2013","unstructured":"Li Y et al (2013) Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology 58:1277\u20131286","journal-title":"Hepatology"},{"key":"4_CR147","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","volume":"154","author":"X Wang","year":"2018","unstructured":"Wang X et al (2018) Dysregulated response of follicular helper T cells to hepatitis B surface antigen promotes HBV persistence in mice and associates with outcomes of patients. Gastroenterology 154:2222\u20132236","journal-title":"Gastroenterology"},{"key":"4_CR148","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","volume":"117","author":"MK Maini","year":"1999","unstructured":"Maini MK et al (1999) Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 117:1386\u20131396","journal-title":"Gastroenterology"},{"key":"4_CR149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.gastro.2012.03.041","volume":"143","author":"E Sandalova","year":"2012","unstructured":"Sandalova E et al (2012) Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells. Gastroenterology 143:78\u201387.e3","journal-title":"Gastroenterology"},{"key":"4_CR150","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Ferrari C, Pasquinelli C, Chisari FV (1996) The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2:1104\u20131108","journal-title":"Nat Med"},{"key":"4_CR151","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","volume":"191","author":"MK Maini","year":"2000","unstructured":"Maini MK et al (2000) The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191:1269\u20131280","journal-title":"J Exp Med"},{"key":"4_CR152","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","volume":"145","author":"C Ferrari","year":"1990","unstructured":"Ferrari C et al (1990) Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145:3442\u20133449","journal-title":"J Immunol"},{"key":"4_CR153","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.180.3.933","volume":"180","author":"A Bertoletti","year":"1994","unstructured":"Bertoletti A et al (1994) Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180:933\u2013943","journal-title":"J Exp Med"},{"key":"4_CR154","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","volume":"78","author":"GJ Webster","year":"2004","unstructured":"Webster GJ et al (2004) Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 78:5707\u20135719","journal-title":"J Virol"},{"key":"4_CR155","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C et al (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81:4215\u20134225","journal-title":"J Virol"},{"key":"4_CR156","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","volume":"161","author":"LG Guidotti","year":"2015","unstructured":"Guidotti LG et al (2015) Immunosurveillance of the liver by intravascular effector CD8(+) T cells. Cell 161:486\u2013500","journal-title":"Cell"},{"key":"4_CR157","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.25730","volume":"56","author":"SP Fletcher","year":"2012","unstructured":"Fletcher SP et al (2012) Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology 56:820\u2013830","journal-title":"Hepatology"},{"key":"4_CR158","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15:486\u2013499","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4_CR159","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77(8):4911\u20134927","journal-title":"J Virol"},{"key":"4_CR160","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro P et al (2010) Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138:682\u2013693. https:\/\/doi.org\/10.1053\/j.gastro.2009.09.052","journal-title":"Gastroenterology"},{"key":"4_CR161","doi-asserted-by":"publisher","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","volume":"7","author":"G Nebbia","year":"2012","unstructured":"Nebbia G et al (2012) Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 7:e47648","journal-title":"PLoS One"},{"key":"4_CR162","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/eji.201141852","volume":"42","author":"W Wu","year":"2012","unstructured":"Wu W et al (2012) Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B. Eur J Immunol 42:1180\u20131191","journal-title":"Eur J Immunol"},{"key":"4_CR163","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","volume":"53","author":"A Schurich","year":"2011","unstructured":"Schurich A et al (2011) Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53:1494\u20131503","journal-title":"Hepatology"},{"key":"4_CR164","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh B et al (2010) The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 52:1934\u20131947","journal-title":"Hepatology"},{"key":"4_CR165","doi-asserted-by":"publisher","first-page":"e1003856","DOI":"10.1371\/journal.ppat.1003856","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J et\u00a0al (2014) Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection. PLoS Pathog 10:e1003856","journal-title":"PLoS Pathog"},{"key":"4_CR166","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1743-422X-10-239","volume":"10","author":"WH Gerlich","year":"2013","unstructured":"Gerlich WH (2013) Medical virology of hepatitis B: how it began and where we are now. Virol J 10:239","journal-title":"Virol J"},{"key":"4_CR167","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(73)92004-7","volume":"2","author":"JH Hoofnagle","year":"1973","unstructured":"Hoofnagle JH, Gerety RJ, Barker LF (1973) Antibody to hepatitis-B-virus core in man. Lancet 2:869\u2013873","journal-title":"Lancet"},{"key":"4_CR168","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/bmj.2.6144.1056","volume":"2","author":"A Alberti","year":"1978","unstructured":"Alberti A, Diana S, Sculard GH, Eddleston AL, Williams R (1978) Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J 2:1056\u20131058","journal-title":"Br Med J"},{"key":"4_CR169","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/infdis\/138.5.625","volume":"138","author":"GF Grady","year":"1978","unstructured":"Grady GF et al (1978) Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 138:625\u2013638","journal-title":"J Infect Dis"},{"key":"4_CR170","doi-asserted-by":"publisher","first-page":"16993","DOI":"10.1073\/pnas.1306437110","volume":"110","author":"L Xu","year":"2013","unstructured":"Xu L, Yin W, Sun R, Wei H, Tian Z (2013) Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice. Proc Natl Acad Sci U S A 110:16993\u201316998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR171","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan H et al (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. elife 1:e00049","journal-title":"elife"},{"key":"4_CR172","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","volume":"65","author":"TY Zhang","year":"2016","unstructured":"Zhang TY et al (2016) Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut 65:658\u2013671","journal-title":"Gut"},{"key":"4_CR173","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/329547a0","volume":"329","author":"DR Milich","year":"1987","unstructured":"Milich DR, McLachlan A, Thornton GB, Hughes JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329:547\u2013549","journal-title":"Nature"},{"key":"4_CR174","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","volume":"55","author":"B Oliviero","year":"2011","unstructured":"Oliviero B et al (2011) Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J Hepatol 55:53\u201360","journal-title":"J Hepatol"},{"key":"4_CR175","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","volume":"189","author":"A Das","year":"2012","unstructured":"Das A et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189:3925\u20133935","journal-title":"J Immunol"},{"key":"4_CR176","first-page":"520","volume":"47","author":"K Araki","year":"1982","unstructured":"Araki K, Nagashima H, Tsuji T (1982) Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis. Clin Exp Immunol 47:520\u2013526","journal-title":"Clin Exp Immunol"},{"key":"4_CR177","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/0016-5085(94)90761-7","volume":"106","author":"T Maruyama","year":"1994","unstructured":"Maruyama T et al (1994) Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 106:1006\u20131015","journal-title":"Gastroenterology"},{"key":"4_CR178","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/JCI121960","volume":"128","author":"AR Burton","year":"2018","unstructured":"Burton AR et al (2018) Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest 128:4588\u20134603","journal-title":"J Clin Invest"},{"key":"4_CR179","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","volume":"128","author":"L Salimzadeh","year":"2018","unstructured":"Salimzadeh L et al (2018) PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Invest 128:4573\u20134587","journal-title":"J Clin Invest"},{"key":"4_CR180","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.3748\/wjg.v23.i43.7657","volume":"23","author":"SY Kim","year":"2017","unstructured":"Kim SY, Kyaw YY, Cheong J (2017) Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases. World J Gastroenterol 23:7657\u20137665","journal-title":"World J Gastroenterol"},{"key":"4_CR181","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1756-8722-6-19","volume":"6","author":"X Li","year":"2013","unstructured":"Li X et al (2013) Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol 6:19","journal-title":"J Hematol Oncol"},{"key":"4_CR182","doi-asserted-by":"publisher","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","volume":"16","author":"HM McBride","year":"2006","unstructured":"McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16:R551\u2013R560","journal-title":"Curr Biol"},{"key":"4_CR183","doi-asserted-by":"publisher","first-page":"22071","DOI":"10.1074\/jbc.M301606200","volume":"278","author":"Y Shirakata","year":"2003","unstructured":"Shirakata Y, Koike K (2003) Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. J Biol Chem 278:22071\u201322078","journal-title":"J Biol Chem"},{"key":"4_CR184","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1128\/JVI.01863-06","volume":"81","author":"S Kim","year":"2007","unstructured":"Kim S et al (2007) Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners. J Virol 81:1714\u20131726","journal-title":"J Virol"},{"key":"4_CR185","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/10409239309086793","volume":"28","author":"MC Sorgato","year":"1993","unstructured":"Sorgato MC, Moran O (1993) Channels in mitochondrial membranes: knowns, unknowns, and prospects for the future. Crit Rev Biochem Mol Biol 28:127\u2013171","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"4_CR186","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1128\/JVI.74.6.2840-2846.2000","volume":"74","author":"Z Rahmani","year":"2000","unstructured":"Rahmani Z, Huh KW, Lasher R, Siddiqui A (2000) Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 74:2840\u20132846","journal-title":"J Virol"},{"key":"4_CR187","doi-asserted-by":"publisher","first-page":"15460","DOI":"10.1074\/jbc.M309280200","volume":"279","author":"YI Lee","year":"2004","unstructured":"Lee YI et al (2004) Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 279:15460\u201315471","journal-title":"J Biol Chem"},{"key":"4_CR188","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1042\/BJ20102071","volume":"435","author":"HK Cho","year":"2011","unstructured":"Cho HK, Cheong KJ, Kim HY, Cheong J (2011) Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4. Biochem J 435:431\u2013439","journal-title":"Biochem J"},{"key":"4_CR189","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1128\/JVI.00172-07","volume":"81","author":"J Chen","year":"2007","unstructured":"Chen J, Siddiqui A (2007) Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol 81:6757\u20136760","journal-title":"J Virol"},{"key":"4_CR190","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/iub.68","volume":"60","author":"HJ Kim","year":"2008","unstructured":"Kim HJ et al (2008) Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life 60:473\u2013480","journal-title":"IUBMB Life"},{"key":"4_CR191","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0092-8674(92)90517-G","volume":"71","author":"D Gorlich","year":"1992","unstructured":"Gorlich D, Prehn S, Hartmann E, Kalies KU, Rapoport TA (1992) A mammalian homolog of SEC61p and SECYp is associated with ribosomes and nascent polypeptides during translocation. Cell 71:489\u2013503","journal-title":"Cell"},{"key":"4_CR192","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/emboj.2010.177","volume":"29","author":"OM Brito de","year":"2010","unstructured":"de Brito OM, Scorrano L (2010) An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J 29:2715\u20132723","journal-title":"EMBO J"},{"key":"4_CR193","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mrfmmm.2004.06.056","volume":"569","author":"M Schroder","year":"2005","unstructured":"Schroder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569:29\u201363","journal-title":"Mutat Res"},{"key":"4_CR194","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","volume":"286","author":"L Ellgaard","year":"1999","unstructured":"Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286:1882\u20131888","journal-title":"Science"},{"key":"4_CR195","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","volume":"97","author":"HC Wang","year":"2006","unstructured":"Wang HC, Huang W, Lai MD, Su IJ (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683\u2013688","journal-title":"Cancer Sci"},{"key":"4_CR196","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/S0002-9440(10)63599-7","volume":"163","author":"HC Wang","year":"2003","unstructured":"Wang HC et al (2003) Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163:2441\u20132449","journal-title":"Am J Pathol"},{"key":"4_CR197","doi-asserted-by":"publisher","first-page":"e34169","DOI":"10.1371\/journal.pone.0034169","volume":"7","author":"C Lazar","year":"2012","unstructured":"Lazar C, Macovei A, Petrescu S, Branza-Nichita N (2012) Activation of ERAD pathway by human hepatitis B virus modulates viral and subviral particle production. PLoS One 7:e34169","journal-title":"PLoS One"},{"key":"4_CR198","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Cacciola I, Saffioti F, Raimondo G (2014) Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications. J Hepatol 61:408\u2013417","journal-title":"J Hepatol"},{"key":"4_CR199","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/jhep.2001.26516","volume":"34","author":"T Kalinina","year":"2001","unstructured":"Kalinina T, Riu A, Fischer L, Will H, Sterneck M (2001) A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology 34:385\u2013394","journal-title":"Hepatology"},{"key":"4_CR200","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1099\/vir.0.012740-0","volume":"91","author":"C Wu","year":"2010","unstructured":"Wu C et al (2010) Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication. J Gen Virol 91:483\u2013492","journal-title":"J Gen Virol"},{"key":"4_CR201","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virusres.2015.08.004","volume":"210","author":"S Li","year":"2015","unstructured":"Li S et al (2015) HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance. Virus Res 210:119\u2013125","journal-title":"Virus Res"},{"issue":"Suppl 4","key":"4_CR202","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/0168-8278(91)90036-B","volume":"13","author":"D Fernholz","year":"1991","unstructured":"Fernholz D, Stemler M, Brunetto M, Bonino F, Will H (1991) Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein. J Hepatol 13(Suppl 4):S102\u2013S104","journal-title":"J Hepatol"},{"key":"4_CR203","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0042-6822(91)90984-J","volume":"183","author":"G Gerken","year":"1991","unstructured":"Gerken G et al (1991) Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology 183:555\u2013565","journal-title":"Virology"},{"key":"4_CR204","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/S0140-6736(88)90541-7","volume":"2","author":"AR Zanetti","year":"1988","unstructured":"Zanetti AR et al (1988) Hepatitis B variant in Europe. Lancet 2:1132\u20131133","journal-title":"Lancet"},{"key":"4_CR205","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0168-8278(97)80239-5","volume":"26","author":"M Sterneck","year":"1997","unstructured":"Sterneck M et al (1997) Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 26:754\u2013764","journal-title":"J Hepatol"},{"key":"4_CR206","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/hep.510260235","volume":"26","author":"T Pollicino","year":"1997","unstructured":"Pollicino T et al (1997) Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26:495\u2013499","journal-title":"Hepatology"},{"key":"4_CR207","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/S0016-5085(97)70018-0","volume":"113","author":"CT Bock","year":"1997","unstructured":"Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C (1997) A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113:1976\u20131982","journal-title":"Gastroenterology"},{"key":"4_CR208","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/hep.510290426","volume":"29","author":"CT Bock","year":"1999","unstructured":"Bock CT, Kubicka S, Manns MP, Trautwein C (1999) Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor. Hepatology 29:1236\u20131247","journal-title":"Hepatology"},{"key":"4_CR209","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/hep.510300206","volume":"30","author":"CT Bock","year":"1999","unstructured":"Bock CT, Tillmann HL, Manns MP, Trautwein C (1999) The pre-S region determines the intracellular localization and appearance of hepatitis B virus. Hepatology 30:517\u2013525","journal-title":"Hepatology"},{"key":"4_CR210","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1128\/JVI.01123-14","volume":"88","author":"L Cao","year":"2014","unstructured":"Cao L et al (2014) Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses. J Virol 88:8656\u20138666","journal-title":"J Virol"},{"key":"4_CR211","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JVI.64.6.2819-2824.1990","volume":"64","author":"J Summers","year":"1990","unstructured":"Summers J, Smith PM, Horwich AL (1990) Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64:2819\u20132824","journal-title":"J Virol"},{"key":"4_CR212","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/hep.510290236","volume":"29","author":"RJ Lenhoff","year":"1999","unstructured":"Lenhoff RJ, Luscombe CA, Summers J (1999) Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus. Hepatology 29:563\u2013571","journal-title":"Hepatology"},{"key":"4_CR213","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/JVI.65.3.1310-1317.1991","volume":"65","author":"J Summers","year":"1991","unstructured":"Summers J, Smith PM, Huang MJ, Yu MS (1991) Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 65:1310\u20131317","journal-title":"J Virol"},{"key":"4_CR214","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/gut.35.8.1013","volume":"35","author":"NV Naoumov","year":"1994","unstructured":"Naoumov NV, Eddleston AL (1994) Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut 35:1013\u20131017","journal-title":"Gut"},{"key":"4_CR215","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G et al (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:652\u2013657","journal-title":"J Hepatol"},{"key":"4_CR216","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3748\/wjg.v22.i13.3531","volume":"22","author":"HL Zhu","year":"2016","unstructured":"Zhu HL, Li X, Li J, Zhang ZH (2016) Genetic variation of occult hepatitis B virus infection. World J Gastroenterol 22:3531\u20133546","journal-title":"World J Gastroenterol"},{"key":"4_CR217","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jhep.2008.04.017","volume":"49","author":"D Candotti","year":"2008","unstructured":"Candotti D et al (2008) Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 49:537\u2013547","journal-title":"J Hepatol"},{"key":"4_CR218","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/hep.22879","volume":"49","author":"JP Allain","year":"2009","unstructured":"Allain JP et al (2009) Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 49:1868\u20131876","journal-title":"Hepatology"},{"key":"4_CR219","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","volume":"57","author":"CH Huang","year":"2012","unstructured":"Huang CH et al (2012) Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720\u2013729","journal-title":"J Hepatol"},{"key":"4_CR220","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4161\/21645515.2014.994461","volume":"11","author":"Q Ye","year":"2015","unstructured":"Ye Q, Shang SQ, Li W (2015) A new vaccine escape mutant of hepatitis B virus causes occult infection. Hum Vaccin Immunother 11:407\u2013410","journal-title":"Hum Vaccin Immunother"},{"key":"4_CR221","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1128\/JVI.02701-12","volume":"87","author":"K Kwei","year":"2013","unstructured":"Kwei K et al (2013) Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J Virol 87:2352\u20132357","journal-title":"J Virol"},{"key":"4_CR222","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/jhg.2016.53","volume":"62","author":"M Otsuka","year":"2017","unstructured":"Otsuka M et al (2017) MicroRNAs and liver disease. J Hum Genet 62:75\u201380","journal-title":"J Hum Genet"},{"key":"4_CR223","doi-asserted-by":"publisher","first-page":"23237","DOI":"10.1038\/srep23237","volume":"6","author":"A Takata","year":"2016","unstructured":"Takata A et al (2016) Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. Sci Rep 6:23237","journal-title":"Sci Rep"},{"key":"4_CR224","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.3748\/wjg.v21.i24.7375","volume":"21","author":"J Lamontagne","year":"2015","unstructured":"Lamontagne J, Steel LF, Bouchard MJ (2015) Hepatitis B virus and microRNAs: complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World J Gastroenterol 21:7375\u20137399","journal-title":"World J Gastroenterol"},{"key":"4_CR225","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep.24809","volume":"55","author":"S Wang","year":"2012","unstructured":"Wang S et al (2012) Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 55:730\u2013741","journal-title":"Hepatology"},{"key":"4_CR226","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1128\/JVI.02831-12","volume":"87","author":"C Li","year":"2013","unstructured":"Li C et al (2013) Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol 87:2193\u20132205","journal-title":"J Virol"},{"key":"4_CR227","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1096\/fj.11-187781","volume":"25","author":"Y Chen","year":"2011","unstructured":"Chen Y et al (2011) A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J 25:4511\u20134521","journal-title":"FASEB J"},{"key":"4_CR228","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2012.10.010","volume":"58","author":"MB Zeisel","year":"2013","unstructured":"Zeisel MB, Pfeffer S, Baumert TF (2013) miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo. J Hepatol 58:821\u2013823","journal-title":"J Hepatol"},{"key":"4_CR229","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","volume":"64","author":"HW Liang","year":"2016","unstructured":"Liang HW et al (2016) Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 64:278\u2013291","journal-title":"J Hepatol"},{"key":"4_CR230","doi-asserted-by":"publisher","first-page":"18484","DOI":"10.1074\/jbc.M113.458158","volume":"288","author":"Y Wang","year":"2013","unstructured":"Wang Y et al (2013) Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a\/miR-16-1 in hepatocytes. J Biol Chem 288:18484\u201318493","journal-title":"J Biol Chem"},{"key":"4_CR231","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.18632\/oncotarget.3652","volume":"6","author":"C Zeng","year":"2015","unstructured":"Zeng C et al (2015) Identification of a novel TGF-beta-miR-122-fibronectin 1\/serum response factor signaling cascade and its implication in hepatic fibrogenesis. Oncotarget 6:12224\u201312233","journal-title":"Oncotarget"},{"key":"4_CR232","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canlet.2016.09.028","volume":"383","author":"M Deng","year":"2016","unstructured":"Deng M et al (2016) Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma. Cancer Lett 383:62\u201372","journal-title":"Cancer Lett"},{"key":"4_CR233","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.canlet.2015.12.008","volume":"371","author":"Y Shi","year":"2016","unstructured":"Shi Y et al (2016) A novel mutant 10Ala\/Arg together with mutant 144Ser\/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. Cancer Lett 371:285\u2013291","journal-title":"Cancer Lett"},{"key":"4_CR234","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4254\/wjh.v8.i25.1061","volume":"8","author":"CC Chao","year":"2016","unstructured":"Chao CC (2016) Inhibition of apoptosis by oncogenic hepatitis B virus X protein: implications for the treatment of hepatocellular carcinoma. World J Hepatol 8:1061\u20131066","journal-title":"World J Hepatol"},{"key":"4_CR235","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0304-3835(02)00187-8","volume":"184","author":"C Yun","year":"2002","unstructured":"Yun C et al (2002) NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett 184:97\u2013104","journal-title":"Cancer Lett"},{"key":"4_CR236","doi-asserted-by":"crossref","first-page":"60962","DOI":"10.18632\/oncotarget.17631","volume":"8","author":"R Dai","year":"2017","unstructured":"Dai R et al (2017) Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells. Oncotarget 8:60962\u201360974","journal-title":"Oncotarget"},{"key":"4_CR237","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1478-3231.2004.0982.x","volume":"24","author":"Y Kondo","year":"2004","unstructured":"Kondo Y et al (2004) Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B. Liver Int 24:561\u2013567","journal-title":"Liver Int"},{"key":"4_CR238","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/vim.2014.0115","volume":"28","author":"D Gogoi","year":"2015","unstructured":"Gogoi D, Borkakoty B, Biswas D, Mahanta J (2015) Activation and exhaustion of adaptive immune cells in hepatitis B infection. Viral Immunol 28:348\u2013353","journal-title":"Viral Immunol"},{"key":"4_CR239","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1073\/pnas.94.16.8744","volume":"94","author":"F Su","year":"1997","unstructured":"Su F, Schneider RJ (1997) Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A 94:8744\u20138749","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR240","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1073\/pnas.1502390112","volume":"112","author":"G Ebert","year":"2015","unstructured":"Ebert G et al (2015) Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proc Natl Acad Sci U S A 112:5797\u20135802","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR241","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1073\/pnas.1502400112","volume":"112","author":"G Ebert","year":"2015","unstructured":"Ebert G et al (2015) Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proc Natl Acad Sci U S A 112:5803\u20135808","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR242","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1074\/jbc.273.1.381","volume":"273","author":"H Kim","year":"1998","unstructured":"Kim H, Lee H, Yun Y (1998) X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 273:381\u2013385","journal-title":"J Biol Chem"},{"key":"4_CR243","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/sj.onc.1205110","volume":"21","author":"O Terradillos","year":"2002","unstructured":"Terradillos O et al (2002) The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Oncogene 21:377\u2013386","journal-title":"Oncogene"},{"key":"4_CR244","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4049\/jimmunol.178.1.503","volume":"178","author":"X Liang","year":"2007","unstructured":"Liang X et al (2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178:503\u2013510","journal-title":"J Immunol"},{"key":"4_CR245","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12985-015-0416-z","volume":"12","author":"F Kong","year":"2015","unstructured":"Kong F et al (2015) The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-alpha related apoptosis inducing ligand) TRAIL in hepatoma cells. Virol J 12:192","journal-title":"Virol J"},{"key":"4_CR246","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2004.08.019","volume":"7","author":"HD Ryoo","year":"2004","unstructured":"Ryoo HD, Gorenc T, Steller H (2004) Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 7:491\u2013501","journal-title":"Dev Cell"},{"key":"4_CR247","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/dev.01432","volume":"131","author":"A Perez-Garijo","year":"2004","unstructured":"Perez-Garijo A, Martin FA, Morata G (2004) Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 131:5591\u20135598","journal-title":"Development"},{"key":"4_CR248","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","volume":"143","author":"P Kennedy","year":"2012","unstructured":"Kennedy P et al (2012) Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 143:637\u2013645","journal-title":"Gastroenterology"},{"key":"4_CR249","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/hep.1840080231","volume":"8","author":"MH Chang","year":"1988","unstructured":"Chang MH, Hwang LY, Hsu HC, Lee CY, Beasley RP (1988) Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 8:374\u2013377","journal-title":"Hepatology"},{"key":"4_CR250","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","volume":"151","author":"WS Mason","year":"2016","unstructured":"Mason WS et al (2016) HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology 151:986\u2013998.e4","journal-title":"Gastroenterology"},{"key":"4_CR251","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/hep.1840080232","volume":"8","author":"HC Hsu","year":"1988","unstructured":"Hsu HC, Lin YH, Chang MH, Su IJ, Chen DS (1988) Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens. Hepatology 8:378\u2013382","journal-title":"Hepatology"},{"key":"4_CR252","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1128\/JVI.02164-09","volume":"84","author":"HY Wang","year":"2010","unstructured":"Wang HY et al (2010) Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J Virol 84:3454\u20133463","journal-title":"J Virol"},{"key":"4_CR253","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","volume":"194","author":"K Kakimi","year":"2001","unstructured":"Kakimi K et al (2001) Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194:1755\u20131766","journal-title":"J Exp Med"},{"key":"4_CR254","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1172\/JCI200421087","volume":"113","author":"G Sitia","year":"2004","unstructured":"Sitia G et al (2004) MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 113:1158\u20131167","journal-title":"J Clin Invest"},{"key":"4_CR255","doi-asserted-by":"publisher","first-page":"13717","DOI":"10.1073\/pnas.172521999","volume":"99","author":"G Sitia","year":"2002","unstructured":"Sitia G et al (2002) Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 99:13717\u201313722","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR256","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim HJ, Lok AS (2006) Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43:S173\u2013S181","journal-title":"Hepatology"},{"key":"4_CR257","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy O (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7:379\u2013390","journal-title":"Nat Rev Immunol"},{"key":"4_CR258","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.194.12.1711","volume":"194","author":"J Geginat","year":"2001","unstructured":"Geginat J, Sallusto F, Lanzavecchia A (2001) Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 194:1711\u20131719","journal-title":"J Exp Med"},{"key":"4_CR259","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1172\/JCI68182","volume":"123","author":"J Publicover","year":"2013","unstructured":"Publicover J et\u00a0al (2013) Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest 123:3728\u20133739","journal-title":"J Clin Invest"},{"key":"4_CR260","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.2604","volume":"14","author":"Y Belkaid","year":"2013","unstructured":"Belkaid Y, Naik S (2013) Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 14:646\u2013653","journal-title":"Nat Immunol"},{"key":"4_CR261","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.smim.2011.11.008","volume":"24","author":"MJ Molloy","year":"2012","unstructured":"Molloy MJ, Bouladoux N, Belkaid Y (2012) Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol 24:58\u201366","journal-title":"Semin Immunol"},{"key":"4_CR262","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1073\/pnas.1424775112","volume":"112","author":"HH Chou","year":"2015","unstructured":"Chou HH et al (2015) Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci U S A 112:2175\u20132180","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR263","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","volume":"44","author":"Y Tian","year":"2016","unstructured":"Tian Y, Kuo CF, Akbari O, Ou JH (2016) Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity 44:1204\u20131214","journal-title":"Immunity"},{"key":"4_CR264","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1056\/NEJM197604012941402","volume":"294","author":"K Okada","year":"1976","unstructured":"Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y (1976) e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 294:746\u2013749","journal-title":"N Engl J Med"},{"key":"4_CR265","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0140-6736(00)90021-7","volume":"355","author":"JS Wang","year":"2000","unstructured":"Wang JS, Zhu QR (2000) Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 355:989","journal-title":"Lancet"},{"key":"4_CR266","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1073\/pnas.87.17.6599","volume":"87","author":"DR Milich","year":"1990","unstructured":"Milich DR et al (1990) Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 87:6599\u20136603","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR267","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona S et al (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38:79\u201391","journal-title":"Immunity"},{"key":"4_CR268","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00005176-199308000-00014","volume":"17","author":"HH Lin","year":"1993","unstructured":"Lin HH, Hsu HY, Chang MH, Chen PJ, Chen DS (1993) Hepatitis B virus in the colostra of HBeAg-positive carrier mothers. J Pediatr Gastroenterol Nutr 17:207\u2013210","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4_CR269","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1038\/ncomms7588","volume":"6","author":"M Hong","year":"2015","unstructured":"Hong M et al (2015) Trained immunity in newborn infants of HBV-infected mothers. Nat Commun 6:6588","journal-title":"Nat Commun"}],"container-title":["Advances in Experimental Medicine and Biology","Hepatitis B Virus Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-9151-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:04:51Z","timestamp":1695420291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-9151-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"ISBN":["9789811391507","9789811391514"],"references-count":269,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-9151-4_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"19 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}